IRIDEX Corporation (IRIX) stock is up 24.64% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With IRIX Stock Today?
IRIDEX Corporation (IRIX) stock is trading at $2.58 as of 11:53 AM on Monday, Aug 10, an increase of $0.29, or 12.45% from the previous closing price of $2.29. The stock has traded between $2.34 and $3.11 so far today. Volume today is above average. So far 126,860 shares have traded compared to average volume of 23,781 shares.
To screen for more stocks like IRIDEX Corporation click here.
More About IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include lasers, laser delivery devices, glaucoma devices, retinal surgical instruments, veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment that is ophthalmology. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific.
